Nalaganje...
Chimeric antigen receptor–modified T cells: CD19 and the road beyond
The ability to harness a patient’s immune system to target malignant cells is now transforming the treatment of many cancers, including hematologic malignancies. The adoptive transfer of T cells selected for tumor reactivity or engineered with natural or synthetic receptors has emerged as an effecti...
Shranjeno v:
| izdano v: | Blood |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6032892/ https://ncbi.nlm.nih.gov/pubmed/29728402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-01-785840 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|